- Home
- GERN vs PBT Comparison
GERN vs PBT Comparison
Compare GERN & PBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- PBT
- Stock Information
- Founded
- GERN 1990
- PBT 1980
- Country
- GERN United States
- PBT United States
- Employees
- GERN N/A
- PBT N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- PBT Oil & Gas Production
- Sector
- GERN Health Care
- PBT Energy
- Exchange
- GERN Nasdaq
- PBT Nasdaq
- Market Cap
- GERN 823.0M
- PBT 838.5M
- IPO Year
- GERN 1996
- PBT N/A
- Fundamental
- Price
- GERN $1.38
- PBT $16.98
- Analyst Decision
- GERN Buy
- PBT
- Analyst Count
- GERN 7
- PBT 0
- Target Price
- GERN $3.17
- PBT N/A
- AVG Volume (30 Days)
- GERN 6.7M
- PBT 110.9K
- Earning Date
- GERN 11-06-2025
- PBT 01-01-0001
- Dividend Yield
- GERN N/A
- PBT 1.93%
- EPS Growth
- GERN N/A
- PBT N/A
- EPS
- GERN N/A
- PBT 0.35
- Revenue
- GERN $164,447,000.00
- PBT $18,413,820.00
- Revenue This Year
- GERN $175.15
- PBT N/A
- Revenue Next Year
- GERN $56.61
- PBT N/A
- P/E Ratio
- GERN N/A
- PBT $48.31
- Revenue Growth
- GERN 11877.20
- PBT N/A
- 52 Week Low
- GERN $1.09
- PBT $8.01
- 52 Week High
- GERN $4.50
- PBT $19.52
- Technical
- Relative Strength Index (RSI)
- GERN 44.59
- PBT N/A
- Support Level
- GERN $1.26
- PBT N/A
- Resistance Level
- GERN $1.48
- PBT N/A
- Average True Range (ATR)
- GERN 0.07
- PBT 0.00
- MACD
- GERN -0.00
- PBT 0.00
- Stochastic Oscillator
- GERN 13.64
- PBT 0.00
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.